Verrieres Le Buisson, France

Catherine Quirosa-Guillou

This inventor holds 2 USPTO granted patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 1996-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Quirosa-Guillou. Retrieved from https://idiyas.com/inventor/catherine-quirosa-guillou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Catherine Quirosa-Guillou: Innovator in Pharmaceutical Compounds

Introduction

Catherine Quirosa-Guillou is a prominent inventor based in Verrieres Le Buisson, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that promote neuronal growth and repair.

Latest Patents

Catherine holds 2 patents related to her innovative work. Her latest patents focus on compounds having a guanidine structure, which are useful for promoting growth, repair, and regeneration of neuronal axons. These compounds are also effective in treating neuropathies and myopathies. The specific formula includes various radicals that enhance the efficacy of these compounds.

Career Highlights

Catherine is affiliated with the Centre National De La Recherche Scientifique, where she conducts her research and development. Her work has been instrumental in advancing the understanding of guanidine derivatives and their applications in medicine.

Collaborations

Catherine has collaborated with notable colleagues, including Claude Thal and Pierre Potier, to further her research and enhance the impact of her inventions.

Conclusion

Catherine Quirosa-Guillou's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in the treatment of neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…